Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with NAFLD non-alcoholic fatty liver disease: results from two early phase randomized trials
| Image |  |
|---|---|
| Description | scientific article published on 02 December 2020 |
| Author/s |
author: Marcus Hompesch Carine Beysen |
| Publication date | December 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |